Results 101 to 110 of about 31,062 (287)

P904 Impact of significant functional mitral regurgitation and aortic stenosis on outcome of HFrEF patients [PDF]

, 2020
Kai Hu, D Liu, Matthias Kirch, F Liebner, C Scheffold, S Herrmann, Frank Weidemann, Björn Lengenfelder, Georg Ertl, Stefan Frantz, Peter Nordbeck   +10 more
openalex   +1 more source

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction [PDF]

, 2018
Background: Information on the pathophysiological differences between heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF) is needed Objectives: The purpose of this study was to establish ...
Anker, Stefan D., Cleland, John G. F., Dickstein, Kenneth, Filippatos, Gerasimos S., Hillege, Hans L., Lang, Chim, Metra, Marco, Ng, Leong Loke, Ouwerkerk, Wouter, Ponikowski, Piotr, Samani, Nilesh J., Tromp, Jasper, van der Harst, Pim, van der Meer, Peter, van Veldhuisen, Dirk Jan, Voors, Adriaan A., Westenbrink, Daan, Zannad, Faiez, Zwinderman, Aelko H.   +18 more
core   +3 more sources

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

ESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén, Bård Andre Bendiksen, Kaja Knudsen Bergo, Emil Knut Stenersen Espe, Gary McGinley, Almira Hasic, Ida Marie Hauge‐Iversen, Hege Katrin Ugland, Xin Shen, Michael Frisk, Nishani S. Mabotuwana, William E. Louch, Rizwan I. Hussain, Lili Zhang, Ivar Sjaastad, Alessandro Cataliotti, Geir Christensen   +16 more
wiley   +1 more source

New in the diagnosis of heart failure and management of associated conditions in 2021 ESC guidelines

Heart Vessels and Transplantation, 2021
Oben Baysan, Ilke Zehra Akyıldız, Yuriy Ivaniv   +2 more
doaj   +1 more source

Impact of diabetes mellitus on right ventricular dysfunction and ventricular interdependence in hypertensive patients with heart failure with reduced ejection fraction assessed via 3.0 T cardiac MRI

Cardiovascular Diabetology
Background Hypertension (HTN) and diabetes mellitus (DM) are two common comorbidities of heart failure with reduced ejection fraction (HFrEF), each of which can cause right ventricular (RV) dysfunction. The aim of this study was to investigate the impact
Ge Zhang, Rui Shi, Xue-Ming Li, Wei-Feng Yan, Hua-Yan Xu, Yuan Li, Ying-Kun Guo, Ke Shi, Zhi-Gang Yang   +8 more
doaj   +1 more source

Coronary Artery Disease Doubles Excess Mortality in Patients With Heart Failure With Reduced Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Assessment of coronary artery disease (CAD) in patients with heart failure and reduced left ventricular ejection fraction (HFrEF) varies between countries and there are only limited data on the long‐term impact of CAD in these patients.
Nanna Anker, Kevin K. W. Olesen, Pernille G. Thrane, Christine Gyldenkerne, Martin B. Mortensen, Roni R. Nielsen, Brian B. Løgstrup, Morten Würtz, Jens C. Nielsen, Michael Maeng   +9 more
doaj   +1 more source

The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectiveness

, 2021
Huai-Wen Liang, Chia‐Te Liao, Wen-Yu Lin, Fa‐Po Chung, Jin‐Long Huang, Ying‐Hsiang Lee, Po-Lin Lin, Wei‐Ru Chiou, Chien‐Yi Hsu, Hung‐Yu Chang   +9 more
openalex   +1 more source

Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure [PDF]

, 2016
OBJECTIVE: Monitoring B-type natriuretic peptide (BNP) to guide pharmacotherapy might improve survival in patients with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).
Dayer, Mark, Hollingworth, William, Macleod, John, Maishman, Rachel, McDonagh, Theresa, Mohiuddin, Syed, Pufulete, Maria, Purdy, Sarah, Reeves, Barnaby, Rogers, Chris   +9 more
core   +1 more source

Prognostic impact of iron deficiency in new‐onset chronic heart failure: Danish Heart Failure Registry insights

ESC Heart Failure, Volume 12, Issue 2, Page 1346-1357, April 2025.
Abstract Aims Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all‐cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new‐onset chronic HF.
Abdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl, Tor Biering‐Sørensen, Morten Lock Hansen, Mariam Elmegaard Malik, Nina Nouhravesh, Charlotte Anderrson, Morten Schou, Gunnar Gislason   +12 more
wiley   +1 more source

The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension [PDF]

, 2015
We assessed the predictive ability of selected biomarkers using N-terminal pro-brain natriuretic peptide (NT-proBNP) as the benchmark and tried to establish a multi-biomarker approach to heart failure (HF) in hypertensive patients. In 120 hypertensive
Agata Bielecka-Dabrowa, Anna Gluba-Brzózka, Campeau, Jacek Rysz, Li, Maciej Banach, Marta Michalska-Kasiczak, Małgorzata Misztal, McCullough, Ravassa, Wei   +10 more
core   +2 more sources